100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
SOCRA CCRP Exam With Verified Answers $12.99   Add to cart

Exam (elaborations)

SOCRA CCRP Exam With Verified Answers

 5 views  0 purchase
  • Course
  • SOCRA CCRP
  • Institution
  • SOCRA CCRP

SOCRA CCRP Exam With Verified Answers

Preview 3 out of 25  pages

  • August 6, 2024
  • 25
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • SOCRA CCRP
  • SOCRA CCRP
avatar-seller
Lectphilip
SOCRA CCRP Exam With Verified Answers

April nn30 nn1996 nn- nnANSWER: nn✔ nnICH nnGCP nnDevelopment nnDate



Quality nn- nnANSWER: nn✔ nnICH nnQ



Efficacy nn- nnANSWER: nn✔ nnICH nnE



Safety nn- nnANSWER: nn✔ nnICH nnS



Multidisciplinary nn- nnANSWER: nn✔ nnICH nnM



guidance nnfor nnindustry, nnconsolidated nnguideance nn- nnANSWER: nn✔ nnICH nnE nn6



Clinical nnSafety nnData nnManagement nnDefinitions nnand nnStandards nn- nnANSWER: nn✔ nnICH nnE2A



Safety nnpharmacology nnstudies nnfor nnhuman nnpharmaceuticals nn- nnANSWER: nn✔ nnICH nnS7A



Electronic nnrecords, nnelectronic nnsignatures nn- nnANSWER: nn✔ nn21 nnCFR nnPart nn11



Informed nnConsent nn- nnANSWER: nn✔ nn21 nnCFR nnPart nn50



Financial nnDisclosures nn- nnANSWER: nn✔ nn21 nnCFR nnPart nn54



Institutional nnReview nnBoard nn- nnANSWER: nn✔ nn21 nnCFR nnPart nn56



IND nnApplication nn- nnANSWER: nn✔ nn21 nnCFR nn312

,New nnDrug nnApplication nn- nnANSWER: nn✔ nn21 nnCFR nn314



Investigational nnDevice nnExemption nn- nnANSWER: nn✔ nn21 nnCFR nn812



21 nnCFR nnPart nn814 nn- nnANSWER: nn✔ nnpre nnmarket nnapproval nnof nnmedical nndevices



45 nnCFR nnPart nn46 nn- nnANSWER: nn✔ nnFederal nnResearch



Studies nnthat nninvestigate nnthe nnpotential nnundesirable nnPD nneffects nnof nna nnsubstance nnon nnphysiological
nnfunctions nnin nnrelation nnto nnexposure nnin nnthe nntherapeutic nnrange nnor nnabove nn- nnANSWER: nn✔ nnSafety

nnPharmacology nnStudies nn(Pre-Clinical)




1) nnTo nnIdentify nnundesirable nnPD nnproperties nnof nna nnsubstance nnthat nnmay nnhave nnrelevance nnto nnits
nnhuman nnsafety. nn



2) nnTo nnevaluate nnadverse nnPD nnand/or nnpathophysio nneffects nnof nna nnsubstance nnobserved nnin nntoxicology
nnstudies



3)to nninvestigate nnthe nnmechanism nnof nnthe nnadverse nnPD nneffects nnobserved nnand/or nnsuspected nn-
nnANSWER: nn✔ nnDrug nnDevelopment nnSafety nnPharmacology nnStudy nnObjectives nn(3)




1) nnCardiovascular

2)Respiratory

3)CNS nn- nnANSWER: nn✔ nnThree nnvital nnorgan nnconsidered nnhighest nnpriority



1) nnPK nnand nntoxicokinetic

2) nnSingle nndose nntoxicity

3) nnRepeated nndose nntoxicity

4) nnLocal nntolerance

5) nnGenotoxicity

6) nnCarcinogenicity

, 7) nnReproduction nntoxicity

8) nnSupplemental nnstudies nnif nnneeded nn- nnANSWER: nn✔ nnTypes nnof nnNon-Clinical nnStudies nn(Animal nnTrials)



Study nnthat nninvestigates nnthe nnmode nnof nnaction nnand/or nneffects nnof nna nndrug nnsubstance nnin nnrelation nnto
nnits nndesired nntherapeutic nntarget nn- nnANSWER: nn✔ nnPrimary nnPharmacodynamic nnStudies




Studies nnthat nninvestigate nnthe nnmode nnof nnaction nnand/or nneffects nnof nna nndrug nnsubstance nnnot nnrelated
nnto nnits nndesire nntherapeutic nntarget nn- nnANSWER: nn✔ nnSecondary nnPharmacodynamic nnStudies




Blood nnPressure

Heart nnRate

ECG/EKG

Repolarization/conductance nnabnormalities nn- nnANSWER: nn✔ nnCore nnBattery nnfor nnCardiovascular nnSystem



Respiratory nnRate

Functional nnAssessments nn(tidal nnvolume, nnhgb nnOxygen nnsaturation) nn- nnANSWER: nn✔ nnCore nnBattery nnfor
nnRespiratory nnSystem




Motor nnactivity

behavioral nnchanges

coordination

sensory/motor nnreflex nnresponse

temperature nn- nnANSWER: nn✔ nnCore nnBattery nnfor nnCentral nnNervous nnSystem



Investigational nnNew nnDrug nnApplication

FDA nn- nnANSWER: nn✔ nnBefore nnclinical nntrials nncan nnbe nninitiated, nnan nnapplication nncontaining nnthe
nnappropriate nninformation nnmust nnbe nnsubmitted nnto nnregulatory nnauthorities, nnin nnthe nnUSA nnthis nnis

nncalled nnXXXX nnand nnsubmitted nnto nnthe nnXXX nn(21 nnCFR nnPart nn312)

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Lectphilip. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $12.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

76658 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$12.99
  • (0)
  Add to cart